| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |